Literature DB >> 12907159

Isolation of a putative keratocyte activating factor from the corneal stroma.

Kurt Musselmann1, Bradley P Kane, John R Hassell.   

Abstract

Fetal bovine serum has commonly been used to expand the population of keratocytes in culture. Tissue extracts, however, have also been used to grow other cell types. We prepared a DMEM/F12 extract of corneal stroma and compared the growth and morphology of collagenase-isolated keratocytes cultured in DMEM/F12, or DMEM/F12 containing either stromal extract or fetal bovine serum. Cell proliferation was measured by 3H-thymidine and BrdU incorporation as well as by DNA quantitation. The extract was fractionated by gel filtration. Cell morphology was assessed by phase-contrast microscopy. Culture in both extract and serum stimulated keratocytes to proliferate, but keratocytes cultured in the extract grew more slowly due to a longer cell cycle and to a lower final density because of greater sensitivity to contact inhibition. Keratocytes cultured in serum became fibroblastic while those cultured in extract retained the dendritic morphology of quiescent keratocytes. The stimulating factors in the corneal extract were more sensitive to heat inactivation and of higher molecular weight than the stimulating factors in serum. These results indicate that the mitogenic activity in extract and serum are different and that the phenotypes resulting from growth in serum and extract are also different. Keratocytes cultured at low cell densities in the corneal extract may mimic keratocyte activation, an initial and crucial event for keratocytes during the corneal wound healing process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12907159     DOI: 10.1016/s0014-4835(03)00160-x

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

1.  Effect of serum and insulin modulation on the organization and morphology of matrix synthesized by bovine corneal stromal cells.

Authors:  Ericka M Bueno; Nima Saeidi; Suzanna Melotti; Jeffrey W Ruberti
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

Review 2.  The molecular basis of corneal transparency.

Authors:  John R Hassell; David E Birk
Journal:  Exp Eye Res       Date:  2010-07-03       Impact factor: 3.467

3.  IGF-II is present in bovine corneal stroma and activates keratocytes to proliferate in vitro.

Authors:  Kurt Musselmann; Bradley P Kane; Bridgette Alexandrou; John R Hassell
Journal:  Exp Eye Res       Date:  2007-12-23       Impact factor: 3.467

4.  MicroRNA signature in wound healing following excimer laser ablation: role of miR-133b on TGFβ1, CTGF, SMA, and COL1A1 expression levels in rabbit corneal fibroblasts.

Authors:  Paulette M Robinson; Tsai-Der Chuang; Sriniwas Sriram; Liya Pi; Xiao Ping Luo; Bryon E Petersen; Gregory S Schultz
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-23       Impact factor: 4.799

Review 5.  The corneal fibrosis response to epithelial-stromal injury.

Authors:  Andre A M Torricelli; Abirami Santhanam; Jiahui Wu; Vivek Singh; Steven E Wilson
Journal:  Exp Eye Res       Date:  2016-01       Impact factor: 3.467

6.  Adipose-derived stem cells differentiate to keratocytes in vitro.

Authors:  Yiqin Du; Danny S Roh; Martha L Funderburgh; Mary M Mann; Kacey G Marra; J Peter Rubin; Xuan Li; James L Funderburgh
Journal:  Mol Vis       Date:  2010-12-10       Impact factor: 2.367

7.  Combined treatment with antioxidants and immunosuppressants on cytokine release by human peripheral blood mononuclear cells - chemically injured keratocyte reaction.

Authors:  Kayoung Yi; Tae Young Chung; Joon Young Hyon; Jae Woong Koh; Won Ryang Wee; Young Joo Shin
Journal:  Mol Vis       Date:  2011-10-15       Impact factor: 2.367

8.  Resolvin D1 attenuates the inflammatory process in mouse model of LPS-induced keratitis.

Authors:  Francesco Petrillo; Maria Consiglia Trotta; Claudio Bucolo; Anca Hermenean; Arianna Petrillo; Rosa Maisto; Gorizio Pieretti; Michela Pietropaolo; Franca Ferraraccio; Caterina Gagliano; Marilena Galdiero; Michele D'Amico
Journal:  J Cell Mol Med       Date:  2020-10-15       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.